This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What could the implications be for patients on their medical cannabis journey? Rescheduling would stand to have the largest impact on cannabis research and business taxes. Cannabis research The Controlled Substances Act requires scientists to register with the DEA if they want to research Schedule I substances.
One in 26 people will develop epilepsy in their lifetime. Medical marijuana can alleviate certain side effects and, some research indicates, reduce the number of seizures a patient experiences. Since each patient’s needs are unique, the certifying physician will make a recommendation based on individual conditions.
SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.
The Office of Drug Control (ODC) issues several license types, including: Cultivation growing cannabis for medicinal or research purposes. Research studying cannabis for medicinal development. Businesses should also investigate potential research and development (R&D) incentives if applicable.
Khon Kaen University has experts and researchers working at the Cannabis Research Institute of the University. Experts at Khon Kaen University (KKU) in Thailand recently gathered to discuss research and academic collaboration related to hemp extraction in order to develop hemp products. Charnchai Panthongviriyakul, M.D.,
It is quite common for cannabis researchers to make use of vertebrates since animals with spines have an endocannabinoid system (ECS), such as mice and rats. Cats do have an ECS, but why use them for research*? As the team stated, aging cats develop cognitive dysfunction as they become older, much like humans.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis research problem. What makes a good research study, anyway?
Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Previous research has found that THC may be effective for some cases that do not respond well to Ritalin. .
The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The psychological symptoms that develop because of the trauma affect mood, cognition, memories (both suppression and the inability to form new memories) and physical health.
There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. For these famous medical cannabis patients and supporters, it is something that can improve quality of life and which should be made readily available to anyone in need. 1) Patrick Stewart. It’s tricky.”.
In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.
According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. Other Research Findings.
Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Additionally, the increase in the availability of cannabis research has led to a decrease in stigmatization attached to cannabis.
Fortunately, Chinese scientists have developed non-hallucinogenic antidepressant compounds. A press release announcing the scientists’ research explains that the team has “designed two new compounds that can relieve depression but do not cause the unwanted effect of hallucination.” Increasing Options for Depression Patients.
CanMar Recruitment is looking for a Director of Business Development and Partnerships for our client in Montreal, Quebec. As Director of Business Development and Partnerships, you are responsible for leading and accelerating business analysis, sourcing, and deal flow activities. About Our Client. About the Role. Responsibilities.
Let’s take a closer look at this new research around CBD for Cerebral Palsy and examine the extent of this trend and its implications for the future of CP management. It occurs due to abnormalities or damage to the developing brain before, during, or after birth. What is Cerebral Palsy?
federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.
annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. How Were the New Guidelines for Cannabis in Chronic Pain Developed?
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .
Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
On top of recognizing the vast scope of benefits cannabis can provide, patients are saving lots of hard-earned money by swapping their pills for cannabis. People often associate pharmaceuticals with being man-made, but some pharmaceutical companies are developing medications made with natural ingredients. pharmaceuticals).
Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches.
Karl Hanes reported on 7 patients with TRD who described relief from depressive symptoms with continued oral consumption of salvia leaves three times a week. We’re thrilled to be pursuing SalA and progressing research, as we strive for new treatments.”. BERLIN, Aug.
The following are some examples of how cannabis can help patients taper off other drugs: Cannabis is a natural treatment for pain and other symptoms of withdrawal. Patients who are prescribed these medications may find that using cannabis helps them to sleep better at night and feel more relaxed during the day.
Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Many patients with OCD tend to perform actions without wanting to, but feeling powerless to try and stop it. What Does Research Say About Cannabis and OCD?
The National Football League has taken proactive steps moving forward into the future with a research grant to explore potential therapeutic attributes of CBD, cannabis, and other options to treat pain other than opioids. NFL Research Grant Will Invest in a Bright Future for Athletes and Others. The opioid epidemic is real.
The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.
million in gifts in support of several causes, including the promotion of arts, Lyme and tick-borne disease research, protection of the environment, and, in this case, psychedelics research. to advance scientific research into the potential therapeutic benefits of psychedelics for mental health and well-being.
Puerto Rico’s Governor has signed legislation into law protecting qualified medical cannabis patients from workplace discrimination. The legislation amends Puerto Rico’s medical marijuana access law so that registered patients are now classified as members of a protected class under the US territory’s employment protection laws.
As the study authors stated: The wider availability [of marijuana] means Parkinson’s patients have more of an opportunity now to experiment with it as a potential means of controlling their symptoms. However, little is known about these patients’ thoughts and experiences related to cannabis, or its perceived effect on the disease’s symptoms.
Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. The stigma is largely due to its association with recreational use and misconceptions about its effects. What is ECS?
Medical marijuana (MMJ) dispensaries play a crucial role in providing patients with access to the cannabis products they need for managing various health conditions. Visiting an MMJ dispensary comes with a set of unwritten rules and etiquettes that patients should be aware of. This is a legal requirement in many states.
Scientists had published legitimate research findings showing that cannabis compounds had actually slowed tumor growth in mice. He developed a concentrated oil from the cannabis plant and decided to try it on himself. He developed a concentrated oil from the cannabis plant and decided to try it on himself. Not Rick Simpson.
If this mechanism is forced to be used repeatedly and often, the body does not properly heal or develop. Often, Post-Traumatic Stress Disorder, a debilitating and chronic illness, can develop. Living with PTSD, no matter the underlying cause of the trauma, can be extremely difficult for patients and their loved ones.
Fernando Fandio-Sende, LifeCannMD After thirty years practicing medicine and specializing as a Miami cannabis doctor , I’ve had countless conversations with patients who tell me the same thing: “Doctor, I want to try medical marijuana , but I’m scared of getting too high.”
An unknown number of recovered COVID-19 patients are walking through a fog, uncertain when it will end and what can be done to help. While the research doesn’t provide any clear answers, here is what we do know. And to make things worse, most of these people were already told that they were “healed.”. What is long COVID?
These essential oils are called Terpenes, and while research is still evolving, science has proven that these oils can drastically improve a patient’s quality of life. This efficacy translates to better medicine and better treatments for patients. Over 100 cannabis-based Terpenes have been discovered. Dogwalker OG.
42 of July 9, 2017, also known as the Act to Manage the Study, Development and Research of Cannabis for Innovation, Applicable Standards and Limits (Medicinal Cannabis Act). This amendment expands employment protections to employees who are registered and licensed medical cannabis patients. Act 15 amends Act No.
This explosion of interest in the use of cannabis and CBD for animals has led to the development of a multi-million dollar industry creating cannabis-based products for pets. In response, veterinarians and others concerned for patient safety promoted a change in state law.
Shanita Penny, President of the Minority Cannabis Business Association (MCBA) said , “The Ending Federal Marijuana Prohibition Act of 2019 removes a roadblock impeding criminal justice reform, patient and consumer access, research and innovation.
Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. The same group of researchers also found that ketamine caused anandamide (one of two major endocannabinoids) to be released in certain brain areas.
Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. So, why did this educational gap develop? Unfortunately, this did not occur.
As the perception of medical marijuana evolves and an increasing number of individuals explore its therapeutic potential, it’s crucial to develop a comprehensive understanding of cannabis’ impact on bodily systems. One area of interest and ongoing research is the relationship between cannabis and the immune system.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content